Mirum Pharmaceuticals Other Long Term Assets (Quarterly) Insights

Mirum Pharmaceuticals, Inc. (MIRM)

91.68 +0.64 (+0.70%) USD | NASDAQ | Jan 20, 16:00

90.46 -1.22 (-1.34%) After-Hours: 20:00

View Other Long Term Assets (Quarterly) for MIRM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
XOMA Royalty Corp.	Upgrade
Arcutis Biotherapeutics, Inc.	Upgrade
Recursion Pharmaceuticals, Inc.	Upgrade
Insmed, Inc.	Upgrade